Mulya.ai
Ticker
DVA
Scenario
Key Inputs
Revenue est.?Analysttaper yr3
OP margin est.?Analyst
Reinvestment est.?avg_lt_ttm
R&D capitalizedNo
Leases factoredYes
Key Assumptions
WACC ?8.3%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?0.931
Beta (levered) ?1.895
Terminal OM% ?14.2%
Segment conc. ?100% dominant
Terminal growth ?4.1%
Bond rating ?A- · 1.45%
ROIC option ?Opt 3 · 10.3%
Prob of failure ?0.0%
Pipeline validated · 2026-05-17

DVA · DaVita Inc.

$145.582026-05-17
Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Services

Intrinsic Value Range Comparison · Mulya.ai

Leases factored
Bull
$196
+34.7% vs market
Base · active
$124
-14.9% vs market
Bear
$119
-18.1% vs market
Mulya.ai vs Analyst IV Comparison?
Bear $119
Base $124
Market $146
Median $158
Bull $196
Market Price $146
Mulya.ai Base $124
Analysts Median $158
Mulya.ai IV range ($119 · $196)
Analysts Range ($158 · $190)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2021.Q4$11.6B16.8%20.2%$1.6B−$2.2B−$686MM6.7%13.5%$11.5B$11.11
2022.Q4$11.6B-0.1%12.5%20.5%$1.2B−$1.4B−$250MM7.9%10.2%$11.2B$6.36
2023.Q4$12.1B4.6%14.3%18.7%$1.4B−$1.7B−$242MM7.7%12.6%$11.2B$7.85
2024.Q4$12.8B5.6%17.7%18.3%$1.9B−$2.4B−$515MM8.3%16.4%$11.4B$10.63
2025.Q4$13.6B6.5%16.2%21.8%$1.7B−$2.5B−$779MM8.1%13.8%$13.6B$8.485.8
italics below = DCF projection · 10yr Rev CAGR: 4.1%
2026.Q4$14.0B+2.5%16.1%21.6%$1.8B−$351MM$1.4B8.3%$1.3B12.8%$14.0B$18.507.9
2027.Q4$14.4B+2.9%18.1%21.4%$2.1B−$420MM$1.6B8.4%$1.4B14.4%$14.4B$21.476.8
2028.Q4$14.8B+3.1%20.0%21.2%$2.3B−$461MM$1.9B8.4%$1.5B15.9%$14.9B$24.436.0
2029.Q4$15.9B+7.3%20.0%21.1%$2.5B−$1.2B$1.4B8.4%$981MM16.3%$16.0B$26.285.5
2030.Q4$16.9B+5.9%20.0%20.9%$2.7B−$1.0B$1.7B8.4%$1.1B16.1%$17.0B$27.885.2
Term. Yr+$21.2B4.1%14.2%20.0%$2.4B−$955MM$1.4B8.6%$14.3B10.3%
Active scenario IV: $124 (-14.9% vs market)